0OR2.LSE LNA Sante SA
- Market cap
- EUR 280M
- P/E
- 9.7x
- P/B
- -
- ROE
- 15.0%
- Dividend yield
- 2.45%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0OR2.LSE undervalued?
Graham numberThe Graham number of LNA Sante SA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
LNA Sante SA fundamental analysis
No fundamental analysis for LNA Sante SA yet.
LNA Sante SA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About LNA Sante SA
LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilitation units; mental health clinics; health centres; and care homes. It also provides respiratory assistance and rehabilitation, cancerology, diabetology, pain management, therapeutic education for the patient and his/her family, geriatrics, enteral and parent…
Full company profileLNA Sante SA financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
LNA Sante SA annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 475M | 487M | 539M | 528M | 574M | 689M | 728M | 736M | 807M | 913M | 1.94B |
| Gross Profit | 53.8M | 130M | 134M | 83.6M | 81.3M | 104M | 113M | 124M | 91.1M | 102M | 227M |
| Operating Income | 36.9M | 37.3M | 39.3M | 53.0M | 42.4M | 45.5M | 39.8M | 61.8M | 69.0M | 75.3M | 142M |
| EBITDA | 45.5M | 46.1M | 50.5M | 112M | 104M | 132M | 142M | 145M | 145M | 159M | 320M |
| Net Income | 21.6M | 24.2M | 21.5M | 20.8M | 7.81M | 23.5M | 25.8M | 23.4M | 21.8M | 24.1M | 50.0M |
| EPS | 2.40 | 2.50 | 2.23 | 2.16 | 0.81 | 2.45 | 2.49 | 2.29 | 2.04 | 2.35 | 4.86 |
| Balance Sheet | |||||||||||
| Total Assets | 668M | 723M | 723M | 1.22B | 1.50B | 1.53B | 1.51B | 1.51B | 1.54B | 1.60B | 1.65B |
| Total Liabilities | 501M | 532M | 515M | 1.02B | 1.29B | 1.30B | 1.21B | 1.20B | 1.21B | 1.26B | 1.31B |
| Shareholders' Equity | 158M | 181M | 197M | 189M | 189M | 216M | 289M | 299M | 314M | 330M | 334M |
| Cash & Short-term Investments | 103M | 163M | 122M | 140M | 121M | 152M | 102M | 77.2M | 75.1M | 94.8M | 89.4M |
| Total Debt | 327M | 348M | 316M | 820M | 973M | 1.00B | 910M | 829M | 876M | 907M | 940M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 24.9M | 54.1M | 42.2M | 118M | 147M | 79.9M | 103M | 97.5M | 82.1M | 70.4M | 105M |
| Capital Expenditure | 9.37M | 7.38M | 9.55M | 5.80M | 9.07M | 10.2M | 12.0M | 11.5M | 10.8M | 11.1M | 24.7M |
| Free Cash Flow | 15.5M | 46.7M | 32.6M | 112M | 137M | 69.7M | 91.2M | 86.0M | 71.2M | 59.3M | 79.8M |
| Ratios | |||||||||||
| ROE | 13.7% | 13.4% | 10.9% | 11.0% | 4.1% | 10.9% | 8.9% | 7.8% | 7.0% | 7.3% | 15.0% |
| ROA | 3.2% | 3.3% | 3.0% | 1.7% | 0.5% | 1.5% | 1.7% | 1.6% | 1.4% | 1.5% | 3.0% |
| Net Profit Margin | 4.6% | 5.0% | 4.0% | 3.9% | 1.4% | 3.4% | 3.5% | 3.2% | 2.7% | 2.6% | 2.6% |
| Debt to Equity | 2.07x | 1.92x | 1.60x | 4.33x | 5.16x | 4.65x | 3.15x | 2.77x | 2.79x | 2.75x | 2.82x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
LNA Sante SA dividends
- Dividend yield
- 2.45%
- Forward dividend
- -
- Payout ratio
- 27.6%
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | 6.67M | 0.65 | 27.6% |
| 2024 | EUR 6.14M | 0.57 | 28.1% |
| 2023 | EUR 5.11M | 0.50 | 21.8% |
| 2022 | EUR 4.52M | 0.44 | 17.5% |
| 2021 | EUR 1.92M | 0.20 | 8.1% |
| 2020 | EUR 4.31M | 0.45 | 55.2% |
| 2019 | EUR 3.67M | 0.38 | 17.6% |
| 2018 | EUR 3.10M | 0.32 | 14.4% |
| 2017 | EUR 2.27M | 0.23 | 9.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns LNA Sante SA
- Insiders 55.22%
- Institutions 11.12%
- Public & others 33.67%
- Shares outstanding 9.68M
- Free float 6.85M
LNA Sante SA company profile
- Company name
- LNA Sante SA
- Ticker
- 0OR2.LSE
- ISIN
- FR0004170017
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 8,777
- Fiscal year end
- December
- Address
- 7 boulevard Auguste Prioué, Vertou, France, 44120
- Phone
- 33 2 40 16 01 61
- Website
- lna-sante.com
About LNA Sante SA
LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilitation units; mental health clinics; health centres; and care homes. It also provides respiratory assistance and rehabilitation, cancerology, diabetology, pain management, therapeutic education for the patient and his/her family, geriatrics, enteral and parenteral nutrition, obstetrics, antenatal and postnatal, complex dressings and specific care, post-operative care, anti-cancer chemotherapy, post-chemotherapy, radiotherapy and aplasia monitoring, psychological or social care, neurological and orthopedic rehabilitation, palliative care, intensive nursing care, intravenous treatment/infusion, blood transfusion, education for the patient and his/her loved ones, paracentesis, pleural or peritoneal drainage, and other treatment services. In addition, the company offers general, ENT, carcinological, digestive and urology, dental, spinal, cosmetic, gynecological and obstetric, maxillo-facial, eye, ENT, orthopedic and trauma, plastic and cosmetic facial, stomatological, urological, vascular, and visceral and digestive surgery, as well as digestive endoscopies and hepato-gastroenterology services. Further, it provides follow-up care clinics or rehabilitation centers, centers for disabled and aging disabled persons, and personal services. LNA Santé SA was founded in 1990 and is based in Vertou, France.
LNA Sante SA management
3- Mr. Jean Paul SiretFounder & Chairman · born 1951
- Mr. Willy SiretMD & Director · born 1974
- Mr. Damien BillardDeputy MD of Finance, CFO & Director · born 1973